NCT01134601 2021-12-01A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the RectumNational Institutes of Health Clinical Center (CC)Phase 1 Terminated1 enrolled 7 charts
NCT01949870 2016-05-13Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 StudyAstraZenecaPhase 1 Terminated6 enrolled 6 charts